ClinicalTrials.gg
Sign In
Drug

Vasopressins clinical trials

studies test it
3
open now
0
in phase 3
0
first study started
2015

How each study uses Vasopressins is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Vasopressins
3

Studies by the year they started

3 studies that test it; most in 2015 (1)

Studies that test Vasopressins, by start year
YearStudies
20151
20171
20181

By phase

A phase 1/2 study counts in both.

Phase 2
1
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Out-of-Hospital Cardiac Arrest
1
Schizophrenia
1
Myoma
1

Who runs them

Industry 0 · Other 3

Asan Medical Center (1) · National Institute of Mental Health and Neuro Sciences, India (1) · University Hospitals Cleveland Medical Center (1)

Studies

Open first, then newest update. How each study uses Vasopressins is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 3

As the comparator · 1 — what is tested is compared with Vasopressins

Codes

What other systems call Vasopressins · ClinicalTrials.gg INT008401

  • MeSH (NLM) D014667VasopressinsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.